Therapeutic treatment
OwnerJallal Messadekinventor
Life of this patent
Estimating the term…
Abstract
The invention describes the use of betaine alone for treating and preventing arterites. The invention also describes an orally administered composition for treating arterites and, in particular, intermittent claudication, said composition containing, as an active ingredient, an active therapeutic quantity of betaine glycine by single dose. The invention particularly describes a medicament provided for treating a patient suffering from an intermittent claudication caused by peripheral circulatory disorders such as arteriosclerosis obliterans or by thromboangiitis obliterans.
Claims20
A method for increasing the initial claudication distance in a patient suffering from peripheral arterial diseases and/or intermittent claudication, said method comprising administering to said patient, as a therapeutically active agent for increasing the initial walking distance, a composition comprising as a single active ingredient a therapeutically effective amount of at least one therapeutically active compound selected from the group consisting of betaine of formula (CH3)3 N+ (CH2)COO−, pharmaceutically active salts thereof and mixtures thereof, so as to increase said initial claudication distance.
A method for treating a patient suffering of peripheral arterial diseases and/or intermittent claudication, said method comprising administering to said patient, as a therapeutically active agent, a composition comprising as a single active ingredient a therapeutically effective amount of at least one therapeutically active compound selected from the group consisting of betaine of formula (CH3)3N+(CH2)COO−, pharmaceutically active salts thereof and mixtures thereof.
Dependencies are inferred from the claim text.